Russell M Nichols (Russell Nichols)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Top Venues

Infectious diseases and therapy

The journal of headache and pain

ClinicoEconomics and outcomes research : CEOR

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Russell M Nichols, Lisa Macpherson, Dipak R Patel, Wendy W Yeh, Amanda Peppercorn
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial. Infectious diseases and therapy 13 (2) (2024)
Russell M Nichols, Lisa Macpherson, Dipak R Patel, Wendy W Yeh, Amanda Peppercorn
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial. Infectious diseases and therapy 13 (2) (2024)
Russell M Nichols, Lisa Macpherson, Dipak R Patel, Wendy W Yeh, Amanda Peppercorn
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial. Infectious diseases and therapy (2024)
Russell M Nichols, Lisa Macpherson, Dipak R Patel, Wendy W Yeh, Amanda Peppercorn
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial. Infectious diseases and therapy 13 (2) (2024)
Sarah Cotton, Jeffrey S Andrews, Russell M Nichols, James Jackson, Antje Tockhorn-Heidenreich, Gary Milligan, James M Martinez
Clinical characteristics and treatment patterns of patients with episodic cluster headache: results from the United States, United Kingdom and Germany. Current medical research and opinion (2023)
Janet Ford, Russell M Nichols, Wenyu Ye, Antje Tockhorn-Heidenreich, Sarah Cotton, James Jackson
Patient-Reported Outcomes for Migraine in the US and Europe: Burden Associated with Multiple Preventive Treatment Failures. ClinicoEconomics and outcomes research : CEOR 13 (2021)
Mamoru Shibata, Tomomi Nakamura, Akichika Ozeki, Kaname Ueda, Russell M Nichols
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study. Journal of pain research 13 (2020)
Russell M Nichols, Vladimir Skljarevski, Grazia Dell'Agnello, Hans-Peter Hundemer, Sheena K Aurora
Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. The journal of headache and pain 20 (1) (2019)